In preclinical models of neurodegeneration, GLP-1R agonists reduce amyloid plaque formation, improve neuronal survival, and reduce neuroinflammation
Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice Michael Camilleri 1 Camille Lupianez-Merly 1 Agonists targeting the receptors of incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, have been well established for the treatment of type 2 diabetes mellitus
Miastenia gravis progresiva, hipotona, letargia
ALCAR has been shown to improve cognitive performance, sustain brain function, and protect against age-related cognitive decline
It reduces time to regenerate the body and boosts production of testosterone
However, a recent clinical trial found contradictory results that 10 MT-II administration before bedtime reduced insulin sensitivity by 12% in men [3]